🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
The primary purpose of this study is to evaluate the pulse wave velocity an...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Start Date
2019-11-11
Trial ID
NCT03841097
Treatments Being Tested
The proposed study is a masked trial, with stratified block randomization b...
Status
Completed
Location
Aravind Eye Hospital
Start Date
2010-10
Trial ID
NCT01232920
Treatments Being Tested
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
The purpose of this study is to determine whether treatment with sirolimus,...
Status
Completed
Location
Children's Hospital
Start Date
2004-03
Trial ID
NCT00188955
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576